Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ADBE -2.9%
Other news:
- SBET -67.1% (files for offering of 58,699,760 shares of common stock by selling shareholders)
- ACHR -14.2% (raises $850 mln following White House Executive Order to accelerate U.S. eVTOL rollout)
- OKLO -5.8% (prices offering of 6,666,667 shares of common stock at a price to the public of $60.00 per share)
- PRO -4.4% (entered into privately-negotiated agreements with existing holders of 2.250% Convertible Senior Notes due 2027; also entered into a Securities Purchase Agreement)
- APLD -3.9% (CoreWeave (CRWV) affirms liquidated stake)
- TLX -3.5% (reports Illuccix prostate cancer PSMA-PET Imaging Agent approved in Greece)
- DKNG -2.6% (will implement 50-cent transaction fee in Illinois)
- INCY -2.5% (Phase 3 Data for Incyte's Retifanlimab (Zynyz) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet)
- ONTO -2.2% (names new CFO)
- NET -2.2% (announces pricing of offering of $1.75 billion of 0% convertible senior notes due 2030)
- BEAM -1.4% (announces new safety and efficacy data from its BEACON Phase 1/2 clinical trial of BEAM-101 in patients with sickle cell disease with severe vaso-occlusive crises)